Skip to main content
. 2014 May 22;2014(5):CD002947. doi: 10.1002/14651858.CD002947.pub2

Comparison 3. Boswellia serrata (enriched) 250 mg versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Pain VAS 0‐100 at 90 days 1   Mean Difference (IV, Random, 95% CI) Totals not selected
2 WOMAC‐VAS (Function) 1   Mean Difference (IV, Random, 95% CI) Totals not selected
3 Adverse event episodes (n) reported 1   Risk Ratio (M‐H, Random, 95% CI) Totals not selected